Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human data for the ChAdOx1 MERS vaccine candidate

April 28, 2020

Enrollment open in phase I/IIa study of PBCAR-269A in relapsed/refractory multiple myeloma

April 28, 2020

Genuv studies trametinib in phase I/IIa trial in Korea for ALS

April 28, 2020

European Commission approves Fetcroja for infections due to aerobic Gram-negative bacteria

April 28, 2020

ENTR-501 corrects metabolic abnormalities in mouse model of MNGIE

April 28, 2020

AACR 2020: Phosphatases are yin to kinases' yang

April 28, 2020

[11C]MK-6884 useful for muscarinic receptor imaging in AD

April 28, 2020

Boehringer Ingelheim identifies new plasma kallikrein inhibitors

April 28, 2020

New TLR7 agonist prodrugs disclosed by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

April 28, 2020

NantBioScience patents dual Wnt/beta-catenin and hedgehog signaling inhibitors

April 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...